Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
- Johns Hopkins School of Medicine
- Johns Hopkins University
- University of Maryland
- National Cancer Institute
- National Cancer Institute,NIH Bethesda, Maryland
- National Cancer Institute, Bethesda, MD
- National Cancer Institute, National Institutes of Health
- BATTELLE (PACIFIC NW LAB)
Many gene products exhibit great structural heterogeneity because of an array of modifications. These modifications are not directly encoded in the genomic template but often affect the functionality of proteins. Protein glycosylation plays a vital role in proper protein functions. However, the analysis of glycoproteins has been challenging compared with other protein modifications, such as phosphorylation. Here, we perform an integrated proteomic and glycoproteomic analysis of 83 prospectively collected high-grade serous ovarian carcinoma (HGSC) and 23 non-tumor tissues. Integration of the expression data from global proteomics and glycoproteomics reveals tumor-specific glycosylation, uncovers different glycosylation associated with three tumor clusters, and identifies glycosylation enzymes that were correlated with the altered glycosylation. In addition to providing a valuable resource, these results provide insights into the potentialroles of glycosylation in the pathogenesis of HGSC, with the possibility of distinguishing pathological outcomes of ovarian tumors from non-tumors, as well as classifying tumor clusters.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC05-76RL01830
- OSTI ID:
- 2565841
- Report Number(s):
- PNNL-SA-160481
- Journal Information:
- Cell Reports, Journal Name: Cell Reports Journal Issue: 3 Vol. 33
- Country of Publication:
- United States
- Language:
- English
Similar Records
Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Biomarkers of high-grade serous ovarian carcinomas
Journal Article
·
Wed Sep 30 20:00:00 EDT 2020
· Cell Reports
·
OSTI ID:2565844
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Journal Article
·
Fri Jul 01 00:00:00 EDT 2016
· Cell
·
OSTI ID:1322516
Biomarkers of high-grade serous ovarian carcinomas
Patent
·
Tue Sep 26 00:00:00 EDT 2017
·
OSTI ID:1532021